Karandeep Singh1,2,3, Clarissa J Diamantidis4,5, Shreyas Ramani3, Nrupen A Bhavsar4, Peter Mara2, Julia Warner2, Jorge Rodriguez6, Tianshi Wang3, Julie Wright-Nunes2. 1. Division of Learning and Knowledge Systems, Department of Learning Health Sciences and kdpsingh@umich.edu. 2. Division of Nephrology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan. 3. School of Information, University of Michigan, Ann Arbor, Michigan. 4. Divisions of General Internal Medicine and. 5. Nephrology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina; and. 6. Department of Clinical Informatics, Lawrence General Hospital, Lawrence, Massachusetts.
Abstract
BACKGROUND AND OBJECTIVES: Many aspects of CKD management rely heavily on patient self-care, including medication and dietary adherence, self-monitoring of BP, and daily physical activity. Growing evidence suggests that incorporating smartphone-based applications can support self-care in CKD and chronic disease more generally. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We identified applications targeting patients with CKD by conducting a search of the US Apple App Store (iOS) and Google Play Store (Android) using the following four phrases: "kidney disease," "renal," "dialysis," and "kidney transplant." We considered the first 50 applications for each search term on each application store. We adapted a previously described framework for assessment of mobile health applications to account for kidney disease-specific content areas and evaluated applications on their types of patient engagement, quality, usability, and safety. Engagement and quality were assessed by both a patient and a nephrologist, usability was assessed by a patient, and safety was assessed by a nephrologist. Overall, two patients with CKD and three nephrologists performed the evaluations. We examined pairwise correlations between patient, nephrologist, and consumer ratings of application quality. RESULTS: Our search strategy identified 174 unique applications on Android and 165 unique applications on iOS. After excluding applications that were not related to kidney disease, were not patient facing, or were last updated before 2014, 12 Android-only applications, 11 iOS-only applications, and five dual-platform applications remained. Patient and nephrologist application quality ratings, assessed by the net promoter score, were not correlated (r=0.36; P=0.06). Consumer ratings on the application stores did not correlate with patient ratings of application quality (r=0.34; P=0.18). CONCLUSIONS: Only a small subset of CKD applications was highly rated by both patients and nephrologists. Patients' impressions of application quality are not directly linked to consumer application ratings or nephrologist impressions.
BACKGROUND AND OBJECTIVES: Many aspects of CKD management rely heavily on patient self-care, including medication and dietary adherence, self-monitoring of BP, and daily physical activity. Growing evidence suggests that incorporating smartphone-based applications can support self-care in CKD and chronic disease more generally. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We identified applications targeting patients with CKD by conducting a search of the US Apple App Store (iOS) and Google Play Store (Android) using the following four phrases: "kidney disease," "renal," "dialysis," and "kidney transplant." We considered the first 50 applications for each search term on each application store. We adapted a previously described framework for assessment of mobile health applications to account for kidney disease-specific content areas and evaluated applications on their types of patient engagement, quality, usability, and safety. Engagement and quality were assessed by both a patient and a nephrologist, usability was assessed by a patient, and safety was assessed by a nephrologist. Overall, two patients with CKD and three nephrologists performed the evaluations. We examined pairwise correlations between patient, nephrologist, and consumer ratings of application quality. RESULTS: Our search strategy identified 174 unique applications on Android and 165 unique applications on iOS. After excluding applications that were not related to kidney disease, were not patient facing, or were last updated before 2014, 12 Android-only applications, 11 iOS-only applications, and five dual-platform applications remained. Patient and nephrologist application quality ratings, assessed by the net promoter score, were not correlated (r=0.36; P=0.06). Consumer ratings on the application stores did not correlate with patient ratings of application quality (r=0.34; P=0.18). CONCLUSIONS: Only a small subset of CKD applications was highly rated by both patients and nephrologists. Patients' impressions of application quality are not directly linked to consumer application ratings or nephrologist impressions.
Authors: Karandeep Singh; Kaitlin Drouin; Lisa P Newmark; JaeHo Lee; Arild Faxvaag; Ronen Rozenblum; Erika A Pabo; Adam Landman; Elissa Klinger; David W Bates Journal: Health Aff (Millwood) Date: 2016-12-01 Impact factor: 6.301
Authors: Stephanie W Ong; Sarbjit V Jassal; Judith A Miller; Eveline C Porter; Joseph A Cafazzo; Emily Seto; Kevin E Thorpe; Alexander G Logan Journal: Clin J Am Soc Nephrol Date: 2016-05-12 Impact factor: 8.237
Authors: Charlene C Quinn; Suzanne Sysko Clough; James M Minor; Dan Lender; Maria C Okafor; Ann Gruber-Baldini Journal: Diabetes Technol Ther Date: 2008-06 Impact factor: 6.118
Authors: Karandeep Singh; Kaitlin Drouin; Lisa P Newmark; Ronen Rozenblum; Jaeho Lee; Adam Landman; Erika Pabo; Elissa V Klinger; David W Bates Journal: Issue Brief (Commonw Fund) Date: 2016-02
Authors: Wim Van Biesen; Vivekanand Jha; Ali K Abu-Alfa; Sharon P Andreoli; Gloria Ashuntantang; Bassam Bernieh; Edwina Brown; Yuqing Chen; Rosanna Coppo; Cecile Couchoud; Brett Cullis; Walter Douthat; Felicia U Eke; Brenda Hemmelgarn; Fan Fan Hou; Nathan W Levin; Valerie A Luyckx; Rachael L Morton; Mohammed Rafique Moosa; Fliss E M Murtagh; Marie Richards; Eric Rondeau; Daniel Schneditz; Kamal D Shah; Vladimir Tesar; Karen Yeates; Guillermo Garcia Garcia Journal: Kidney Int Suppl (2011) Date: 2020-02-19
Authors: Anders Nikolai Ørsted Schultz; Jan Dominik Kampmann; Kristian Kidholm; Caroline Moos; Eithne Hayes Bauer Journal: BMJ Open Date: 2022-07-18 Impact factor: 3.006
Authors: Sarah J Schrauben; Lawrence Appel; Eleanor Rivera; Claudia M Lora; James P Lash; Jing Chen; L Lee Hamm; Jeffrey C Fink; Alan S Go; Raymond R Townsend; Rajat Deo; Laura M Dember; Harold I Feldman; Clarissa J Diamantidis Journal: Am J Kidney Dis Date: 2020-12-09 Impact factor: 11.072